Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
260.00    -2.50 (-0.95%)
Bid:
255.00
Ask:
265.00
Spread: 10.00 (3.922%)
Market Cap: £125.98m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Directorate Changes

26 Jul 2017 07:00

RNS Number : 0789M
Quartix Holdings PLC
26 July 2017
 

26 July 2017

Quartix Holdings plc

("Quartix" or the "Company")

Directorate changes

Quartix Holdings plc, a leading supplier of subscription-based vehicle tracking systems, software and services in the UK, is pleased to announce the appointment of Ed Ralph as Chief Operating Officer. Ed joined the Company in February this year and yesterday, at a committee meeting of the board to approve the interim results, was appointed to the Board of Quartix Holdings plc.

Ed brings to Quartix extensive experience and a proven track record in technology management, digital marketing and eCommerce. From 2001 to 2015 he built and led the technology team at Abcam plc ("Abcam"), having joined the company as the seventh employee and at a time when its revenues were just £200k. After leaving Abcam Ed served in non-executive or consultancy roles related to technology and marketing at a range of Cambridge-based companies, including Red Gate Software, Axol Bioscience and Congenica. During this time he also conducted consulting projects for Quartix in 2016 before joining the Company full time in February 2017.

Ed has a first-class honours degree in biochemistry from Southampton University, a PhD in molecular biology and biotechnology from Sheffield University and was conducting post-doctoral research at the University of Cambridge prior to joining Abcam.

Commenting on the appointment, Andy Walters, Managing Director of Quartix, said: "Having worked with Ed since last year, I am delighted that he is now joining the Board in this senior executive role. Ed brings proven skills in digital marketing, technology and eCommerce which will be invaluable to Quartix in the next stage of its development."

The Company is also announcing today that, following 10 years of exceptional service to the business, David Bridge, the Company's Finance Director, has indicated that he would like to retire from the business at some point in 2018. David remains committed to the company and will work with the rest of the Board to ensure that an orderly transition is achieved. Plans to recruit a successor for David are already well underway, and a further announcement concerning his appointment will be made in due course.

Andy Walters commented: "I would like to record my personal thanks for the enormous contribution that David has made to the business since he joined as Finance Director in January 2008. He will be greatly missed and we wish him well for the future."

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Managing Director

David Bridge, Finance Director

 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode/Scott Mathieson (Corporate Finance)

Stephen Norcross/Alice Lane (Corporate Broking)

020 7220 0500

 

Additional information:

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Edward Tatsuya Ralph, aged 42, has been a director of the following companies during the five years preceding the date of this announcement

Current directorships

Past directorships

Quartix Ltd

 

Axol Bioscience Ltd

 

At the date of this announcement, Mr Ralph holds 79,795 ordinary shares in the Company, representing 0.17% of the Company's issued share capital.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXXSAEFXEFF
Date   Source Headline
25th Jul 20187:00 amRNSInterim Results
2nd Jul 20187:00 amRNSTrading Statement
26th Apr 20182:58 pmRNSDirector Share Transfer
23rd Apr 20187:00 amRNSQueen?s Award for Enterprise
27th Mar 20182:46 pmRNSExercise of Options
27th Mar 20182:42 pmRNSResult of AGM
27th Mar 20187:00 amRNSTrading Statement
12th Mar 20186:10 pmRNSDirector/PDMR Shareholding
26th Feb 20187:00 amRNSFinal Results
16th Jan 20185:33 pmRNSDirector/PDMR Shareholding
12th Jan 20187:00 amRNSTrading Statement
1st Dec 20171:29 pmRNSIssue of Equity & Directorate Changes
10th Nov 20177:00 amRNSHolding(s) in Company
8th Nov 20173:25 pmRNSHolding(s) in Company
27th Sep 20177:00 amRNSDirectorate Change
1st Aug 20177:00 amRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSDirectorate Changes
26th Jul 20177:00 amRNSInterim Results
3rd Jul 20177:00 amRNSTrading Update
21st Jun 20177:00 amRNSExercise of Options
18th Apr 201712:20 pmRNSDirector/PDMR Shareholding
13th Apr 20175:00 pmRNSHolding(s) in Company
30th Mar 201712:20 pmRNSHolding(s) in Company
30th Mar 20178:01 amRNSHolding(s) in Company
28th Mar 20171:20 pmRNSExercise of Options
28th Mar 201711:40 amRNSResult of AGM
28th Mar 20177:00 amRNSAGM Statement
9th Mar 201710:10 amRNSExercise of Options
2nd Mar 201711:13 amRNSDirector/PDMR Shareholding
27th Feb 20177:00 amRNSFinal Results
18th Jan 20177:00 amRNSTrading Statement
22nd Dec 20161:41 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSHolding(s) in Company
9th Aug 20169:13 amRNSExercise of Options
5th Aug 20164:12 pmRNSHolding(s) in Company
1st Aug 20169:43 amRNSPDMR Shareholding
27th Jul 20167:00 amRNSInterim Results
1st Jul 20167:00 amRNSTrading Update
19th Apr 20161:55 pmRNSDirector Share Transfer
4th Apr 20167:00 amRNSHolding(s) in Company
29th Mar 201612:16 pmRNSResult of AGM
29th Mar 20167:00 amRNSAGM Statement
29th Feb 20161:42 pmRNSExercise of Options
29th Feb 20167:00 amRNSFinal Results
15th Jan 20167:00 amRNSTrading Statement
21st Dec 20157:00 amRNSHolding in Company
17th Dec 20151:43 pmRNSExercise of Warrants
27th Oct 20153:00 pmRNSFRS 101 Adoption
23rd Oct 20154:10 pmRNSHolding(s) in Company
22nd Oct 20153:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.